Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zuora Inc (NY: ZUO )

9.385 +0.115 (+1.24%)
Streaming Delayed Price Updated: 11:13 AM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Zuora Inc

< Previous 1 2 3 4 5 Next >
United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were lower, with the Dow Jones index falling over 50 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
3 Unloved Software Stocks That Could Rebound 1,000%
These overlooked software stocks have strong growth prospects and could potentially surge as investors recognize their true potential. 
Via InvestorPlace
Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Friday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Navigating 5 Analyst Ratings For Zuora
Via Benzinga
Zuora: Q4 Earnings Insights
Via Benzinga
A Glimpse Into The Expert Outlook On Zuora Through 4 Analysts
Via Benzinga
Why Zuora Stock Dropped This Week
Management lowered their fiscal year sales and earnings outlook. 
Via The Motley Fool
Earnings Outlook For Zuora
Via Benzinga
Earnings Scheduled For February 28, 2024
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion. 
Via Benzinga
Analyst Expectations for Zuora's Future
Via Benzinga
7 Millionaire-Maker Tech Stocks to Buy Before They Quadruple
Look beyond the big tech winners. These under-the-radar tech stocks could have explosive return potential in the years ahead. 
Via InvestorPlace
Enphase Energy To Rally Over 35%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
12 Information Technology Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Stocks, Gold, Bonds Rally Further, Dollars Tumbles As Traders Anticipate Fed Cuts: What's Driving Markets Friday?
Kicking off the new month, Wall Street continued its strong November momentum, with major U.S. stocks rallying on Friday. 
Via Benzinga
Topics Economy
Exposures Interest Rates
S&P 500, Nasdaq Slip As Tech Underperforms, Oil Reacts to OPEC+: What's Driving Markets Thursday?
Thursday’s trading session on Wall Street presents a mixed picture, characterized by notable fluctuations in major indices. While tech-heavy benchmarks like the S&P 500 and the Nasdaq 100 are... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results. 
Via Benzinga
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq, S&P 500 Futures Rally As Market Looks Set To Finish A Strong November On Upbeat Note
US stocks are priming for a positive start Thursday, with stock futures higher ahead of an inflation data, which the Fed deems as important. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Information Technology Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Stocks Drift Higher On Stronger GDP Data, Oil Rebounds As OPEC+ Mulls Cuts: What's Driving Markets Wednesday?
Stocks are experiencing their 16th green session out of the 20 so far in November, with the S&P 500 index reaching its highest level since early August, and the Nasdaq 100 just 4.4% below its all-time... 
Via Benzinga
Earnings Scheduled For November 29, 2023
Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per share on revenue of $3.50 million. 
Via Benzinga
US Stocks On Track For Strong Start With VIX Plunging: Why This Analyst Says Next Move 'More Likely Higher Than Lower'
After stocks scraped through on Wednesday, the market mood has lifted from a general increase in risk appetite. With volatility plunging, all risky bets, such as equities and cryptocurrencies, are... 
Via Benzinga
Topics Bonds Stocks
Exposures Debt Markets Fossil Fuels US Equities
Pearson Taps Microsoft Veteran Omar Abbosh As Next CEO
Pearson, Plc (NYSE: PSO) appointed Omar Abbosh as its new Chief Executive Officer and  
Via Benzinga
Dollar Tree, Burlington Stores, Opera And Other Big Stocks Moving Lower On Thursday
U.S. stocks traded lower, with the Dow Jones falling over 100 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Splunk Are Trading Higher By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Electriq Power Holdings, Inc. (NYSE: ELIQ) shares jumped 130.3% to $3.3847. 
Via Benzinga
Earnings Scheduled For August 23, 2023
Companies Reporting Before The Bell • ATRenew (NYSE:RERE) is estimated to report quarterly earnings at $0.06 per share on revenue of $397.98 million. 
Via Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.